Source link : https://www.newshealth.biz/health-news/experts-discuss-groundbreaking-advances-in-egfr-mutant-lung-cancer/
In a comprehensive discussion of EGFR-mutant non-small cell lung cancer at the American Society of Clinical Oncology (ASCO) annual meeting, a number of significant advancements were highlighted, particularly from the LAURA trial, which showed improved progression-free survival with osimertinib (Tagrisso) in patients with locally advanced disease. MedPage Today brought together three expert leaders in the […]
Author : News Health
Publish date : 2024-07-03 17:06:31
Copyright for syndicated content belongs to the linked Source.
Categories